---
document_datetime: 2023-09-21 21:47:03
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/nevirapine-teva-epar-all-authorised-presentations_en.pdf
document_name: nevirapine-teva-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0436301
conversion_datetime: 2025-12-21 23:27:18.969446
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging                                             | Pack size                              |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------------------------------------------------|----------------------------------------|
| EU/1/09/598/001  | Nevirapine Teva   | 200 mg     | Tablet                | Oral use                  | blister (PVC/PE/PVdC/alu)                                       | 60 tablets                             |
| EU/1/09/598/002  | Nevirapine Teva   | 200 mg     | Tablet                | Oral use                  | blister (PVC/PE/PVdC/alu)                                       | 120 tablets                            |
| EU/1/09/598/003  | Nevirapine Teva   | 200 mg     | Tablet                | Oral use                  | blister (OPA/alu/PVC/alu)                                       | 60 tablets                             |
| EU/1/09/598/004  | Nevirapine Teva   | 200 mg     | Tablet                | Oral use                  | blister (OPA/alu/PVC/alu)                                       | 120 tablets                            |
| EU/1/09/598/005  | Nevirapine Teva   | 200 mg     | Tablet                | Oral use                  | calendar blister (PVC/PE/PVdC/alu) (OPA/alu/PVC/alu) authorised | Initiation pack: 14 tablets 14 tablets |
| EU/1/09/598/006  | Nevirapine Teva   | 200 mg     | Tablet                | Oral use                  | calendar blister                                                | Initiation pack:                       |

<!-- image -->